Photoaffinity probe‐based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of Plasmodium falciparum
Peng Gao,
Jianyou Wang,
Chong Qiu,
Huimin Zhang,
Chen Wang,
Ying Zhang,
Peng Sun,
Honglin Chen,
Yin Kwan Wong,
Jiayun Chen,
Junzhe Zhang,
Huan Tang,
Qiaoli Shi,
Yongping Zhu,
Shengnan Shen,
Guang Han,
Chengchao Xu,
Lingyun Dai,
Jigang Wang
Affiliations
Peng Gao
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Jianyou Wang
State Key Laboratory of Antiviral Drugs, School of Pharmacy Henan University Kaifeng China
Chong Qiu
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Huimin Zhang
Shandong Academy of Chinese Medicine Jinan China
Chen Wang
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Ying Zhang
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Peng Sun
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Honglin Chen
State Key Laboratory of Antiviral Drugs, School of Pharmacy Henan University Kaifeng China
Yin Kwan Wong
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Jiayun Chen
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Junzhe Zhang
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Huan Tang
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Qiaoli Shi
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Yongping Zhu
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Shengnan Shen
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Guang Han
State Key Laboratory of Antiviral Drugs, School of Pharmacy Henan University Kaifeng China
Chengchao Xu
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Lingyun Dai
Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, and Shenzhen Clinical Research Centre for Geriatrics Shenzhen People's Hospital; First Affiliated Hospital of Southern University of Science and Technology Shenzhen China
Jigang Wang
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medical China Academy of Chinese Medical Sciences Beijing China
Abstract Malaria continues to pose a serious global health threat, and artemisinin remains the core drug for global malaria control. However, the situation of malaria resistance has become increasingly severe due to the emergence and spread of artemisinin resistance. In recent years, significant progress has been made in understanding the mechanism of action (MoA) of artemisinin. Prior research on the MoA of artemisinin mainly focused on covalently bound targets that are alkylated by artemisinin‐free radicals. However, less attention has been given to the reversible noncovalent binding targets, and there is a paucity of information regarding artemisinin targets at different life cycle stages of the parasite. In this study, we identified the protein targets of artemisinin at different stages of the parasite's intraerythrocytic developmental cycle using a photoaffinity probe. Our findings demonstrate that artemisinin interacts with parasite proteins in vivo through both covalent and noncovalent modes. Extensive mechanistic studies were then conducted by integrating target validation, phenotypic studies, and untargeted metabolomics. The results suggest that protein synthesis, glycolysis, and oxidative homeostasis are critically involved in the antimalarial activities of artemisinin. In summary, this study provides fresh insights into the mechanisms underlying artemisinin's antimalarial effects and its protein targets.